News - Page 184 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial

MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial

Post published:May 17, 2021
Post category:Press Release

Read more about the article Filament Announces C$10M Offering and Filing of Initial Listing Application

Filament Announces C$10M Offering and Filing of Initial Listing Application

Post published:May 17, 2021
Post category:Press Release

Read more about the article BetterLife Announces Closing of a Non-Brokered Private Placement

BetterLife Announces Closing of a Non-Brokered Private Placement

Post published:May 14, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Provides Corporate Update

Entheon Biomedical Corp. Provides Corporate Update

Post published:May 14, 2021
Post category:Press Release

Read more about the article MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m CAD) to Execute on Diverse Clinical Pipeline

MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD ($194m CAD) to Execute on Diverse Clinical Pipeline

Post published:May 14, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: MAPS Study Published in Nature Medicine; Numinus’ Hiring Spree; CB Therapeutics’ Series A

Psychedelic Bulletin: MAPS Study Published in Nature Medicine; Numinus’ Hiring Spree; CB Therapeutics’ Series A

Post published:May 14, 2021
Post category:Psychedelic Bulletin

Read more about the article IntelGenx Announces Initial Closing of atai Investment

IntelGenx Announces Initial Closing of atai Investment

Post published:May 14, 2021
Post category:Press Release

Read more about the article MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director

MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director

Post published:May 14, 2021
Post category:Press Release

Read more about the article COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021

COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021

Post published:May 13, 2021
Post category:Press Release

Read more about the article PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and Grants Him Options and Promotes Him to Chief Scientific Officer for All of Pharmadrug

PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and Grants Him Options and Promotes Him to Chief Scientific Officer for All of Pharmadrug

Post published:May 13, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.